The use of quantitative clinical pharmacology approaches to support moxidectin dosing recommendations in lactation.

• Main Authors: Nolan D Wood (Author), Danelle Smith (Author), Sally A Kinrade (Author), Mark T Sullivan (Author), Craig R Rayner (Author), David Wesche (Author), Kashyap Patel (Author), Karen Rowland-Yeo (Author)
• Format: Book
• Published: Public Library of Science (PLoS), 2024-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Moxidectin is approved by the US Food and Drug Administration (US FDA) for the treatment of onchocerciasis (river-blindness) due to Onchocerca volvulus in patients aged 12 years and older. In onchocerciasis-endemic areas, mass drug administration (MDA) programs with ivermectin, with or without vecto...